Based in Virginia, ivWatch is a trailblazer in the medical field, utilizing advanced non-invasive technology to detect early signs of peripheral IV infiltrations and extravasations. The company’s state-of-the-art technology uses advanced optics to monitor a patient’s IV status in real-time, enabling quick detection of infiltrations, and alerting clinicians up to 15 hours before they might otherwise notice a problem. The recent inclusion of ivWatch in the ivWatch National Patient Safety Board Advocacy Coalition reinforces the company’s commitment to patient safety globally. This partnership aims to address the growing issue of IV injury in the U.S. and is a significant step towards reducing preventable medical harm. As a local business, ivWatch exemplifies the potential of small companies to make a global impact, pioneering biosensor technology to enhance the safety and efficacy of intravenous therapy.
About ivWatch
Based in the heart of Hampton Roads, Virginia, ivWatch stands as a beacon of innovation in the medical field. Founded with a singular vision – elevating patient care by detecting early signs of peripheral IV (PIV) infiltrations and extravasations – this local enterprise has become an exemplar of success in a short span of time.
Advanced Non-Invasive Technology
Peripheral IV infiltrations can lead to dosing errors, causing significant complications that are often preventable. ivWatch’s state-of-the-art non-invasive technology harnesses advanced optics to monitor a patient’s IV status in real-time. This allows for the rapid detection of infiltrations, sometimes as early as 0.2 mL of IV fluid, well before a human eye can discern them. Moreover, the system’s capability to notify clinicians up to 15 hours before they might otherwise notice an issue empowers medical professionals to act swiftly, ultimately reducing negative patient outcomes and streamlining their workflow.
Commitment to Patient Safety
The recent announcement of ivWatch joining the National Patient Safety Board (NPSB) Advocacy Coalition has further cemented their commitment to global patient safety. Just as the National Transportation Safety Board (NTSB) has been pivotal in ensuring transportation safety, the NPSB aims to champion patient safety in healthcare. ivWatch’s alignment with the NPSB’s vision underscores its unwavering dedication to safeguarding patients from unforeseen IV complications.
Addressing IV Injury Issue
Christine Hayden, RN, BSN, ivWatch’s Director of Business Development, highlighted the urgency of addressing the escalating IV injury issue in the U.S., “The alarming escalation of IV injury in the U.S. is a perfect case study for why a National Patient Safety Board is imperative right now.” Given the alarming fact that medical errors, before the onset of the COVID-19 pandemic, were the third leading cause of death in the U.S., ivWatch’s partnership with the NPSB is a significant leap towards curbing preventable medical harm.
Mission and Impact
ivWatch CEO, Gary Warren, in emphasizing the importance of their mission, notes that the vast majority of hospital patients undergo a procedure involving vascular access. But the simplicity of this common procedure belies the risks, from skin necrosis and scarring to dire outcomes like amputation in severe cases.
As a proud Hampton Roads company, ivWatch epitomizes the potential of local businesses to make global impacts. By pioneering biosensor technology to boost the safety and efficacy of intravenous therapy, ivWatch not only underscores the importance of innovative healthcare solutions but also shines as a beacon of hope for a safer medical future.
Question & Answer
What is ivWatch?
ivWatch is a trailblazer in the medical field, utilizing advanced non-invasive technology to detect early signs of peripheral IV infiltrations and extravasations.
How does ivWatch’s technology work?
ivWatch’s state-of-the-art technology uses advanced optics to monitor a patient’s IV status in real-time, enabling quick detection of infiltrations and alerting clinicians up to 15 hours before they might otherwise notice a problem.
Why did ivWatch join the ivWatch National Patient Safety Board Advocacy Coalition?
ivWatch joined the ivWatch National Patient Safety Board Advocacy Coalition to address the growing issue of IV injury in the U.S. and to take significant steps towards reducing preventable medical harm.
Who highlighted the urgency of addressing the escalating IV injury issue in the U.S.?
Christine Hayden, RN, BSN, ivWatch’s Director of Business Development, highlighted the urgency of addressing the escalating IV injury issue in the U.S.
What is ivWatch’s mission?
ivWatch’s mission is to pioneer biosensor technology to enhance the safety and efficacy of intravenous therapy, exemplifying the potential of local businesses to make a global impact.
